pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
gedeptin
Nasopharyngeal Cancer
$GOVXGeoVax Labs, Inc.
0 catalysts
Marketed
gefitinib
Gefitinib (gefitinib)
Non-Small Cell Lung Cancer
Actavis Laboratories NY Inc (Inactive)
0 catalysts
pre_registration
gefurulimab
Myasthenia Gravis
Alexion Pharmaceuticals Inc
0 catalysts
Phase 1
← prev
page 182 of 231
next →
131
Pain89
Neurology1
gemcitabine
Avgemsi (gemcitabine)
Pancreatic Cancer
Continuity Biosciences LLC
0 catalysts
Marketed
gemfibrozil
Gemfibrozil (gemfibrozil)
Hyperlipidemia
Nivagen Pharmaceuticals Inc
0 catalysts
Phase 2
gemlapodect
Stammering (Stuttering)
Noema Pharma AG
0 catalysts
Phase 2
gemogenovatucel-T
Vigil (gemogenovatucel-T)
Endometrial Cancer
Gradalis Inc
0 catalysts
Marketed
gemtuzumab ozogamicin
Mylotarg (gemtuzumab ozogamicin)
Refractory Acute Myeloid Leukemia
$PFEPFIZER INC
0 catalysts
Phase 2
genistein
Pulmonary Fibrosis
Humanetics Corp
0 catalysts
Marketed
gentamicin sulfate
Gentamicin Sulfate (gentamicin sulfate)
Bacterial Blepharoconjunctivitis
Fera Pharmaceuticals LLC
0 catalysts
Preclinical
gentulizumab
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Changchun High-Tech Industry Group Co Ltd
0 catalysts
Marketed
gepirone hydrochloride ER
Exxua (gepirone hydrochloride)
Major Depressive Disorder
Fabre-Kramer Pharmaceuticals Inc
0 catalysts
Phase 2
gilavebexagene anvuparvovec
Tay-Sachs Disease
University of Massachusetts
0 catalysts
Phase 3
gildeuretinol acetate
Juvenile Macular Degeneration (Stargardt Disease)
Alkeus Pharmaceuticals Inc
0 catalysts
Marketed
gilteritinib fumarate
Xospata (gilteritinib fumarate)
Refractory Acute Myeloid Leukemia
Astellas Pharma US Inc
0 catalysts
Phase 1
gintemetostat tartrate
Refractory Multiple Myeloma
K36 Therapeutics Inc
0 catalysts
pre_registration
giredestrant
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Estrogen receptor
Genentech Inc
0 catalysts
Marketed
givinostat hydrochloride
Duvyzat (givinostat hydrochloride)
Polycythemia Vera
Histone deacetylase
Italfarmaco SpA
0 catalysts
Marketed
givosiran
Givlaari (givosiran)
Acute Intermittent Porphyria
$ALNYALNYLAM PHARMACEUTICALS, INC.
0 catalysts
Marketed
glacial acetic acid
Acetic Acid (ACETIC ACID)
Otitis Externa
Sciegen Pharmaceuticals Inc
0 catalysts
Marketed
glasdegib
Daurismo (glasdegib)
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
$PFEPFIZER INC
0 catalysts
Phase 2
glecirasib
glecirasib [INN]
Non-Small Cell Lung Cancer
Jacobio Pharmaceuticals Group Co Ltd
0 catalysts
Phase 3
glenzocimab
Acute Ischemic Stroke
Platelet glycoprotein VI
Acticor Biotech SAS
0 catalysts
Marketed
glimepiride
Glimepiride (glimepiride)
Type 2 Diabetes
Carlsbad Technology Inc
0 catalysts
Marketed
glipizide
Glipizide (glipizide)
Type 2 Diabetes
Graviti Pharmaceuticals Inc
0 catalysts
Marketed
glucagon
Gvoke (glucagon [INN])
Hypoglycemia
$XERSXeris Biopharma Holdings, Inc.
0 catalysts
Marketed
glucarpidase
Voraxaze (glucarpidase [INN])
Chemotherapy Effects
BTG International Inc
0 catalysts
Phase 3
glufosfamide
glufosfamide [INN]
Metastatic Adenocarcinoma of The Pancreas
Eleison Pharmaceuticals Inc
0 catalysts
Phase 3
glyburide
Cirara (glyburide)
Diabetes
Sulfonylurea receptor 1, Kir6.2
$ETONEton Pharmaceuticals, Inc.
0 catalysts
Marketed
glycopyrronium tosylate
Qbrexza (glycopyrronium tosylate)
Axillary Hyperhidrosis
$DERMJourney Medical Corp
0 catalysts